Skip to main content


Page 3 of 41

  1. Depression is associated with an increased risk for type 2 diabetes mellitus. However, depression may take different courses, and it is not fully understood how these affect the development of diabetes. It is ...

    Authors: Felix S. Wicke, Daniëlle Otten, Andreas Schulz, Philipp S. Wild, Karl J. Lackner, Thomas Münzel, Jochem König, Mareike Ernst, Jörg Wiltink, Iris Reiner, Jasmin Ghaemi Kerahrodi, Norbert Pfeiffer and Manfred E. Beutel
    Citation: Diabetology & Metabolic Syndrome 2024 16:34
  2. Glucose-to-glycated hemoglobin ratio (GAR) is considered a more reliable marker of stress hyperglycemia by correcting for basal blood glucose levels. This study aimed to investigate the extent to which GAR is ...

    Authors: Bing Yang, Xuefang Chen, Fangze Li, Junrun Zhang, Dawei Dong, Huiyue Ou, Longyan Lu, Niu He, Xiaohong Xu, Xiufeng Xin, Jingchong Lu, Min Guan, Hongyu Qiao, Anding Xu and Huili Zhu
    Citation: Diabetology & Metabolic Syndrome 2024 16:32
  3. The primary aim of this study was to evaluate the prevalence of autoimmune diseases (AIDs) and its associated factors in an admixed Brazilian population of patients with type 1 diabetes (T1D). The secondary on...

    Authors: Marilia Brito Gomes, Fernanda Oliveira Braga, Karla Guerra Drummond, André Pinheiro, Franz Leal, Luís Cristóvão Porto, Livia Leite Ferreira, Geraldo da Rocha Castelar Pinheiro and Carlos Antonio Negrato
    Citation: Diabetology & Metabolic Syndrome 2024 16:31
  4. We aimed to explore the associations between urine albumin-to-creatinine ratio (uACR) and cardia-cerebrovascular disease (CVD) in Chinese population with type 2 diabetes(T2D).

    Authors: Jie Tao, Dasen Sang, Xinxin Zhang, Xin Liu, Guodong Wang, Shuohua Chen, Shouling Wu and Wei Geng
    Citation: Diabetology & Metabolic Syndrome 2024 16:30
  5. Triglyceride glucose index (TyG index) was related with both type 2 diabetes (T2DM) and hypertension (HTN). Prospective studies linking the TyG index to the incidence of T2DM and HTN comorbidity remain unclear...

    Authors: Wanlu Su, Jie Wang, Kang Chen, Wenhua Yan, Zhengnan Gao, Xulei Tang, Qin Wan, Zuojie Luo, Guang Ning and Yiming Mu
    Citation: Diabetology & Metabolic Syndrome 2024 16:29
  6. Throughout the COVID-19 pandemic, there has been a notable increase in the incidence of new-onset diabetes and diabetic ketoacidosis (DKA). Simultaneously, children diagnosed with type 1 diabetes (T1D) have en...

    Authors: Zhaoyuan Wu, Jinling Wang, Rahim Ullah, Minghao Chen, Ke Huang, Guanping Dong and Junfen Fu
    Citation: Diabetology & Metabolic Syndrome 2024 16:28
  7. The effect of obesity in different glucose tolerance statuses i.e. normoglycemia (NGT), pre-diabetes, and type 2 diabetes (T2DM) on cardiovascular disease (CVD) and mortality has been an area of ongoing debate...

    Authors: Samaneh Asgari, Danial Molavizadeh, Kiarash soltani, Davood Khalili, Fereidoun Azizi and Farzad Hadaegh
    Citation: Diabetology & Metabolic Syndrome 2024 16:27
  8. Immune checkpoint inhibitors (ICI) are promising treatment options for various cancers. However, their use is associated with immune-related adverse events (irAEs), including ICI-induced diabetes mellitus (ICI...

    Authors: Hung-Hui Wei, Ying-Chieh Lai, Gigin Lin, Cheng-Wei Lin, Ya-Chu Chang, John Wen-Cheng Chang, Miaw-Jene Liou and I-Wen Chen
    Citation: Diabetology & Metabolic Syndrome 2024 16:26
  9. Abnormalities in glucose and lipid metabolism contribute to the progression and exacerbation of type 2 diabetes mellitus (T2DM). Fish oil and probiotics are dietary supplements that have the potential to impro...

    Authors: Mei Zhang, Fan Yang, Qiu Feng, Yanghong Ou, Jiaxing Zhang, Haiyan Wan, Hongyi Cao and Peng Ning
    Citation: Diabetology & Metabolic Syndrome 2024 16:25
  10. Our objective was to evaluate how various measures of obesity, such as body mass index(BMI), body roundness index(BRI), and weigh adjusted waist index(WWI), influence urate levels, prevalence of gout and to co...

    Authors: Tongjun Mao, Qian He, Junping Yang, Lanlan Jia and Guofei Xu
    Citation: Diabetology & Metabolic Syndrome 2024 16:24
  11. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease affecting 30% of the world’s population and is often associated with metabolic disorders such as metabolic synd...

    Authors: Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto and Marcello Casaccia Bertoluci
    Citation: Diabetology & Metabolic Syndrome 2024 16:23

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2024 16:54

  12. To assess the prevalence of alterations in anthropometric parameters predictive of metabolic syndrome and cardiovascular risk among childhood brain tumor survivors.

    Authors: Alberto Romano, Mariapia Masino, Serena Rivetti, Stefano Mastrangelo, Giorgio Attinà, Palma Maurizi and Antonio Ruggiero
    Citation: Diabetology & Metabolic Syndrome 2024 16:22
  13. Time in range (TIR), as an important glycemic variability (GV) index, is clearly associated with disease complications in type 1 diabetes (T1D). Metabolic dysregulation is also involved in the risks of T1D com...

    Authors: Liyuan Ma, Jieying Liu, Mingqun Deng, Liyuan Zhou, Qian Zhang and Xinhua Xiao
    Citation: Diabetology & Metabolic Syndrome 2024 16:21
  14. Body mass index (BMI) is an important risk factor for hypertension in diabetic patients. However, the underlying mechanisms remain poorly understood. Although liver-derived biological intermediates may play ir...

    Authors: Xuelin Yao, Keyan Hu, Zhen Wang, Fangting Lu, Jie Zhang, Yahu Miao, Qing Feng, Tian Jiang, Yi Zhang, Songtao Tang, Nan Zhang, Fang Dai, Honglin Hu and Qiu Zhang
    Citation: Diabetology & Metabolic Syndrome 2024 16:19
  15. Diabetes mellitus (DM) and its associated vascular complications have become a worldwide health concern. The effects and mechanism of vitamin D supplementation on endothelial function under high glucose condit...

    Authors: Zhoujun Liu, Haogang Sun, Yu Chen, Jia He, Lin Zhu, Bing Yang and Wenzhuo Zhao
    Citation: Diabetology & Metabolic Syndrome 2024 16:18
  16. To identify the gestational weight gain (GWG) patterns in women with gestational diabetes mellitus (GDM) and evaluate their association with offspring weight status from birth to 40 months.

    Authors: Wei Zheng, Jia Wang, Yichen Li, Xiaorui Shang, Kaiwen Ma, Xianxian Yuan, Kexin Zhang, Ruihua Yang, Yuru Ma and Guanghui Li
    Citation: Diabetology & Metabolic Syndrome 2024 16:17
  17. This study aimed to compare and analyze the expression and significance of the GRP78 protein in cochlear cell injury induced by a high glucose and high-fat diet in obese and diabetic rats.

    Authors: Kai Xi, Hua-Ping Li, Yue-Hui Wang, Yang-Yang Li, Lei Wang, Miao-Miao Zhang, Xi Zhang and Bing-Wen Xing
    Citation: Diabetology & Metabolic Syndrome 2024 16:16
  18. To explore the relationship between sleep patterns and cardiovascular disease (CVD) incidence and mortality risk in a population with type 2 diabetes through a UK Biobank sample.

    Authors: Jinxia Hu, Xuanyang Wang, Licheng Cheng, Keke Dang, Zhu Ming, Xinmiao Tao, Xiaoqing Xu, Shuvan Kumar Sarker and Ying Li
    Citation: Diabetology & Metabolic Syndrome 2024 16:15
  19. To assess the effects of finerenone and glucagon-like peptide 1 receptor agonists (GLP1-RA) on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus (T2DM), and the relative cardiovascula...

    Authors: Xia Gu, Shimin Jiang, Yue Yang and Wenge Li
    Citation: Diabetology & Metabolic Syndrome 2024 16:14
  20. Inflammatory bowel disease (IBD) has been associated with lipid-lowering drugs in observational studies. Drug-target Mendelian randomization (MR) was utilized in this study to examine the causal relationship b...

    Authors: Jiaxi Zhao, Rong Chen, Mengqi Luo, Hongping Gong, Kaixin Li and Qian Zhao
    Citation: Diabetology & Metabolic Syndrome 2024 16:12
  21. Accompanying islet α- and β-cell dysregulation in type 2 diabetes (T2D) at the microscopic scale, alterations in body composition at the macroscopic scale may affect the pathogenesis of T2D. However, the conne...

    Authors: Jia-xi Miao, Jia-ping Xu, Rui Wang, Yu-xian Xu, Feng Xu, Chun-hua Wang, Chao Yu, Dong-mei Zhang and Jian-bin Su
    Citation: Diabetology & Metabolic Syndrome 2024 16:11
  22. The Steno Diabetes Center Copenhagen developed the Steno T1 Risk Engine (ST1RE) to predict cardiovascular events, encompassing fatal and nonfatal ischemic heart disease, ischemic stroke, heart failure, and per...

    Authors: Fabiano Malard de Araujo, Fábio Vasconcellos Comim, Rodrigo N. Lamounier, Natália F. Pena, Virgínia C. Fajardo, Regina Bicalho G. de Faria, Yuri M. Silva and Márcio Weissheimer Lauria
    Citation: Diabetology & Metabolic Syndrome 2024 16:10
  23. Type 2 diabetes mellitus (T2DM), one of the most common public diseases threatening human health, is always accompanied by infection. Though there are still a variety of flaws in the treatment of some infectio...

    Authors: Jing-Xi Zhang, Wei-Ming Luo, Bo-Wen Wang, Ru-Tao Li, Qian Zhang, Xiang-Yu Zhang, Zhong-Ze Fang and Zhi-Peng Zhang
    Citation: Diabetology & Metabolic Syndrome 2024 16:9
  24. Women at risk of gestational diabetes mellitus (GDM) need preventative interventions.

    Authors: Ola F. Quotah, Daria Andreeva, Katarzyna G. Nowak, Kathryn V. Dalrymple, Aljawharah Almubarak, Anjali Patel, Nirali Vyas, Gözde S. Cakir, Nicola Heslehurst, Zoe Bell, Lucilla Poston, Sara L. White and Angela C. Flynn
    Citation: Diabetology & Metabolic Syndrome 2024 16:8
  25. Prolonged exposure to plasma free fatty acids (FFAs) leads to impaired glucose tolerance (IGT) which can progress to type 2 diabetes (T2D) in the absence of timely and effective interventions. High-fat diet (H...

    Authors: Jingwen Yang, Ying Zou, Xiaoyu Lv, Jun Chen, Chen Cui, Jia Song, Mengmeng Yang, Huiqing Hu, Jing Gao, Longqing Xia, Liming Wang, Li Chen and Xinguo Hou
    Citation: Diabetology & Metabolic Syndrome 2024 16:7
  26. Obesity is a chronic, recurring, progressive disease and a major public health problem associated with several other diseases that lead to disability, morbidity, and mortality. The prevalence of obesity has in...

    Authors: Walmir Coutinho and Bruno Halpern
    Citation: Diabetology & Metabolic Syndrome 2024 16:6
  27. Atherosclerotic cardiovascular disease (ASCVD) consistently ranks as the primary mortality factor among diabetic people. A thorough comprehension of the pathophysiological routes and processes activated by ath...

    Authors: Shan-shan Yu and Jian-ling Du
    Citation: Diabetology & Metabolic Syndrome 2024 16:5
  28. Intermittent fasting (IF) is a commonly used dietary practice that alternates between periods of unrestricted dietary consumption and abstinence from caloric intake. IF reduces caloric intake along with metabo...

    Authors: Yasmin Atwa Mohamed, Megahed Abouelmagd, Aya Elbialy, Mona Elwassefy and Fady Kyrillos
    Citation: Diabetology & Metabolic Syndrome 2024 16:4
  29. Randomized controlled trials have found that once-weekly insulin resulted in greater glycemic control compared to once-daily insulin in patients with type 2 diabetes. However, no direct comparisons have been m...

    Authors: Peng Wang, Yu Zhang, Wenhao Xu, Jialing He, Liyuan Peng, Yuning Feng, Ping Xu, Weelic Chong, Yang Hai, Lu Jia and Fang Fang
    Citation: Diabetology & Metabolic Syndrome 2024 16:3
  30. Glycemic control for patients with diabetes in the surgical department is often unsatisfactory. Compounding this issue is the fact that conventional glucose management models are often inefficient and difficul...

    Authors: Jiayu Lin, Jinying Zhang, Bo Liang, Jinkuang Lin, Neng Wang, Jialin Lin and Huibin Huang
    Citation: Diabetology & Metabolic Syndrome 2024 16:2
  31. Triglyceride glucose (TyG) is associated with stroke, atherosclerosis, and adverse clinical outcomes. However, its correlation with cerebrovascular disease (CVD) mortality remains unclear. This study aimed to ...

    Authors: Yong’An Jiang, Peng Chen, YangYang Zhao, JiaHong Cai, JiaWei Liang, ShiQi Cheng and Yan Zhang
    Citation: Diabetology & Metabolic Syndrome 2024 16:1
  32. Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes mellitus (T2DM). HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. HIC is originally calcu...

    Authors: Tsuyoshi Okura, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroko Okura, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-ichi Taniguchi and Kazuhiro Yamamoto
    Citation: Diabetology & Metabolic Syndrome 2023 15:261
  33. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is considered a new biomarker for atherosclerosis, but its ability to predict cardiovascular outcomes has been controversial. This study aimed to address t...

    Authors: Juan Huang, Jun-Xu Gu, Kun Wang, Ai-Min Zhang, Ting-Ting Hong, Shan-Shan Li, Xiao-Qin Yao, Ming Yang, Yue Yin, Na Zhang, Ming Su, Jia-Jia Hu, Xue-Zhi Zhang and Mei Jia
    Citation: Diabetology & Metabolic Syndrome 2023 15:260
  34. The relationship between the non-high-density lipoprotein to high-density lipoprotein ratio (non-HDL-c/HDL-c ratio) and changes in glycemic status as well as the development of type 2 diabetes mellitus (T2DM) ...

    Authors: Zihe Mo, Yong Han, Changchun Cao, Qingli Huang, Yanhua Hu, Zhiqun Yu and Haofei Hu
    Citation: Diabetology & Metabolic Syndrome 2023 15:259
  35. To estimate the contemporary prevalence of established cardiovascular disease (CVD) in adults with type 2 diabetes (T2D) in Mexico.

    Authors: José L. Arenas-León, Enrique C. Morales-Villegas, Ernesto G. Cardona-Muñoz, Marco A. Alcocer-Gamba, Juan P. Ramirez-Contreras, Aleida Y. Contreras-Sandoval and Guillermo González-Galvez
    Citation: Diabetology & Metabolic Syndrome 2023 15:258
  36. Ramadan Iftar meal typically causes glucose excursions. Dipeptidyl peptidase-4 inhibitors increase glucagon-like peptide-1 and thus, decrease blood glucose levels with low risk of hypoglycemia.

    Authors: Nancy Samir Elbarbary and Eman Abdel Rahman Ismail
    Citation: Diabetology & Metabolic Syndrome 2023 15:257
  37. Sodium-dependent glucose transporter 2 inhibitor (SGLT2i) has the advantages of effectively lowering blood glucose levels and improving renal outcomes in diabetic patients. This study evaluated the effect of c...

    Authors: Li Zhang, Tongdan Wang, Yan Kong, Haizhen Sun, Yuling Zhang, Junmei Wang, Zhida Wang, Shan Lu, Pei Yu and Saijun Zhou
    Citation: Diabetology & Metabolic Syndrome 2023 15:256
  38. It has not been clarified whether physical activity (PA) has more benefit in terms of health outcomes, including mortality risk, among those with metabolic syndrome (MS) compared to those without. Therefore, t...

    Authors: Chang-Hoon Lee, Kyung-Do Han and Min-Sun Kwak
    Citation: Diabetology & Metabolic Syndrome 2023 15:255
  39. Data on hyperglycemia and glucose variability in relation to diabetes mellitus, either known or unknown in ICU-setting in COVID-19, are scarce. We prospectively studied daily glucose variables and mortality in...

    Authors: Thijs T.W. van Herpt, Frank van Rosmalen, Hendrica P.M.G. Hulsewé, Anouk N.A. van der Horst-Schrivers, Mariëlle Driessen, Robin Jetten, Noortje Zelis, Bastiaan E. de Galan, Sander M.J. van Kuijk, Iwan C.C. van der Horst and Bas C.T. van Bussel
    Citation: Diabetology & Metabolic Syndrome 2023 15:253
  40. Increasing number of studies reported the positive effect of metformin on the prevention and treatment of cancers. However, the genetic causal effect of metformin utilization on the risk of common cancers was ...

    Authors: Yao Chen, Bingjun Bai, Shuchang Ye, Xing Gao, Xinnan Zheng, Kangkang Ying, Hongming Pan and Binbin Xie
    Citation: Diabetology & Metabolic Syndrome 2023 15:252
  41. Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduced the risk of cardiovascular and renal outcomes in patients with type 2 diabetes (T2D), but the underlying mechanism has not been well elucidated. The c...

    Authors: Jia Liu, Xiaona Chang, Xiaoyu Ding, Xueqing He, Jiaxuan Wang and Guang Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:251
  42. The increased prevalence of insulin resistance is one of the major health risks in society today. Insulin resistance involves both short-term dynamics, such as altered meal responses, and long-term dynamics, s...

    Authors: Tilda Herrgårdh, Christian Simonsson, Mattias Ekstedt, Peter Lundberg, Karin G. Stenkula, Elin Nyman, Peter Gennemark and Gunnar Cedersund
    Citation: Diabetology & Metabolic Syndrome 2023 15:250
  43. The risk factors for hypoglycemia during hospital admission and its consequences in patients with diabetes are not entirely known. The present study aimed to investigate the risk factors for hypoglycemia, as w...

    Authors: Tomás González-Vidal, Diego Rivas-Otero, Alba Gutiérrez-Hurtado, Carlos Alonso Felgueroso, Gema Martínez Tamés, Carmen Lambert, Elías Delgado-Álvarez and Edelmiro Menéndez Torre
    Citation: Diabetology & Metabolic Syndrome 2023 15:249
  44. The association between insulin resistance and urinary incontinence (UI) has not been investigated widely. The purpose of this study is to assess the relationship between a novel indicator for assessing insuli...

    Authors: Shangqi Cao, Linghao Meng, Lede Lin, Xu Hu and Xiang Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:248
  45. The relationship between leukocyte telomere length (LTL) and mortality risk in individuals with metabolic syndrome (MetS) remains poorly understood. This study aimed to investigate the association between telo...

    Authors: Lijiao Xiong, Guangyan Yang, Tianting Guo, Zhaohao Zeng, Tingfeng Liao, Yanchun Li, Ying Li, Fujuan Chen, Shu Yang, Lin Kang and Zhen Liang
    Citation: Diabetology & Metabolic Syndrome 2023 15:247
  46. Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed t...

    Authors: Qi Zhou, Hongyi Yan, Aoming Jin, Xia Meng, Jinxi Lin, Hao Li, Yongjun Wang and Yuesong Pan
    Citation: Diabetology & Metabolic Syndrome 2023 15:246
  47. Diabetes is a complicated, chronic condition that requires ongoing medical attention as well as multiple risk-reduction measures beyond glucose control. The prevalence of chronic kidney disease (CKD) is highly...

    Authors: Eneyew Talie Fenta, Habitu Birhan Eshetu, Natnael Kebede, Eyob Ketema Bogale, Amare Zewdie, Tadele Derbew Kassie, Tadele Fentabil Anagaw, Elyas Melaku Mazengia and Sintayehu Shiferaw Gelaw
    Citation: Diabetology & Metabolic Syndrome 2023 15:245

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    1,058 Altmetric mentions